The Watchman device is a small implant placed inside the heart to lower the risk of stroke in certain people with atrial fibrillation (AFib). It seals off a pouch in the heart where dangerous blood clots can form. The device may help people who cannot safely take blood-thinning medicines for the long term.
How Does the Watchman Device Prevent Strokes?
Atrial fibrillation is an irregular heart rhythm that affects the heart's upper chambers. When these chambers do not squeeze normally, blood may move more slowly and collect in certain areas of the heart.
One area where blood can collect is the left atrial appendage (LAA), a small pouch attached to the upper left chamber of the heart. Blood that remains in this pouch can form clots. If a clot travels to the brain and blocks an artery, it can cause an ischemic stroke.
The Watchman device works by sealing the opening of the left atrial appendage. This helps prevent clots that form inside the pouch from entering the bloodstream.
According to the American Heart Association, closing the left atrial appendage can lower stroke risk and may allow some people with AFib to stop taking long-term anticoagulant medicines.
The Watchman device does not correct the irregular heartbeat itself. Its purpose is to reduce the risk of stroke caused by clots originating in the left atrial appendage. People may still need medications or other treatments to manage their AFib.
Who Is a Good Candidate for the Watchman Device?
The Watchman device is primarily considered for adults with nonvalvular atrial fibrillation who have an increased risk of stroke and a reason to avoid long-term blood-thinning treatment.
Nonvalvular AFib generally refers to atrial fibrillation that is not associated with a mechanical heart valve or moderate-to-severe mitral stenosis. These conditions can require different approaches to preventing blood clots.
A cardiologist may consider the Watchman device when a person:
- Has atrial fibrillation and an increased risk of stroke.
- Has experienced significant bleeding while taking anticoagulant medication.
- Has a medical condition that makes long-term anticoagulant treatment unsafe.
- Has a high risk of serious bleeding associated with long-term anticoagulant use.
- Has an appropriate medical reason to consider a device-based alternative to long-term blood thinners.
The decision depends on the person's stroke risk, bleeding risk, medical history, heart anatomy, and ability to take medications after the procedure.
The American Heart Association's 2023 atrial fibrillation guideline summary supports the use of left atrial appendage closure devices in selected patients who have contraindications to long-term anticoagulation.
Having AFib does not automatically mean someone needs a Watchman device. For many people, oral anticoagulant medications remain an effective and appropriate first-choice treatment for stroke prevention.
What Happens During the Watchman Implant Procedure?
The Watchman device is implanted through a minimally invasive procedure called percutaneous left atrial appendage closure. It usually does not require opening the chest or performing traditional open-heart surgery.
Before the procedure, the care team uses imaging tests to examine the left atrial appendage, check for existing blood clots, and determine whether the device will fit properly. These tests may include a transesophageal echocardiogram (TEE), which uses ultrasound imaging from the esophagus, or a cardiac CT scan.
During the procedure, the medical team generally follows these steps:
- Anesthesia: The patient receives anesthesia or sedation to remain comfortable during implantation.
- Catheter insertion: The doctor inserts a thin, flexible tube called a catheter into a vein near the groin.
- Guiding the catheter: The catheter travels through the blood vessels to the heart. The doctor makes a small opening in the wall between the two upper heart chambers to reach the left atrium.
- Device placement: The folded Watchman device moves through the catheter into the left atrial appendage, where it expands to cover the opening.
- Position check: The medical team uses imaging to confirm that the device is positioned securely and provides an adequate seal.
- Catheter removal: Once the device is properly positioned and released, the catheter is removed. The Watchman implant remains in the heart permanently.
Johns Hopkins Medicine explains that the Watchman device expands inside the left atrial appendage and that heart tissue gradually grows over it after implantation, helping create a lasting barrier.
The amount of time needed for implantation and observation depends on the patient and the medical center. Some patients can leave the hospital the following day, while others need additional monitoring.
What Are the Benefits of a Watchman Device?
The main benefit of the Watchman device is lowering the risk of stroke associated with clots forming in the left atrial appendage.
Reduced dependence on long-term blood thinners
Blood-thinning medicines help prevent clots, but they can also increase bleeding risk. For patients who have difficulty continuing these medicines safely, the Watchman device offers another approach to stroke prevention.
After successful implantation and follow-up assessment, some patients can discontinue long-term oral anticoagulants. However, the device does not guarantee that every patient can stop these medications, especially if they have another condition requiring anticoagulation.
A minimally invasive procedure
Because the device is delivered through a catheter rather than a large chest incision, recovery is generally shorter than recovery from open-heart surgery.
Long-term protection without replacing the device routinely
The Watchman device is designed to remain in the heart permanently. Once heart tissue grows over it and the appendage is adequately sealed, the implant continues to serve as a barrier between the pouch and the circulating blood.
Although the implant can reduce stroke risk, it cannot eliminate every possible cause of stroke. Managing blood pressure, diabetes, cholesterol, and other cardiovascular risk factors remains important.
What Are the Possible Risks and Complications?
Watchman implantation is an established procedure, but it carries risks because it involves placing a device inside the heart.
According to Cleveland Clinic, potential complications of left atrial appendage closure include bleeding, infection, abnormal heart rhythms, stroke, fluid around the heart, and device-related problems.
Possible complications include:
- Bleeding: Bleeding may occur near the catheter insertion site or internally.
- Pericardial effusion: Fluid or blood can collect around the heart and may require treatment.
- Device-related problems: The implant may not completely seal the appendage or may develop another complication.
- Blood clots: Clots may develop on the device, particularly before tissue has fully covered it.
- Stroke: A stroke can occur during or after implantation, although the procedure is intended to reduce long-term stroke risk.
- Infection or anesthesia complications: These may occur with catheter-based procedures.
Serious complications are uncommon, but the possibility matters when choosing between the device and medication. An implanting cardiologist can explain the expected benefits and procedural risks for a particular patient.
What Is Recovery Like After Watchman Implantation?
Many patients recover relatively quickly after a catheter-based Watchman procedure. Some return home the next day, depending on their condition and whether complications occur.
Patients may experience temporary soreness or bruising near the groin where the catheter entered the blood vessel.
During the initial recovery period, the healthcare team may recommend avoiding heavy lifting, strenuous exercise, or activities that place pressure on the catheter insertion site. The timing for returning to normal activities depends on the patient's recovery and discharge instructions.
Will blood thinners still be needed after the procedure?
Yes, medication that reduces clot formation is usually needed for a period after implantation. This helps prevent clots from forming on the device while tissue grows over it.
The exact medication plan varies according to the device used, the patient's bleeding risk, and the cardiologist's assessment. Some patients receive an oral anticoagulant along with aspirin initially. Others may be prescribed a different combination of antithrombotic medications.
The first important follow-up imaging assessment is often performed about 45 days after implantation. The healthcare team checks whether the device is sealing the appendage properly and whether any clots have developed around it.
Medication may then be adjusted based on the imaging results. Some patients continue antiplatelet medication, such as aspirin or clopidogrel, for a longer period.
Patients should never stop or change these medicines without instructions from their treating clinician, even when they feel well.
Why are follow-up heart scans important?
Follow-up imaging helps confirm that the device is stable, that the appendage is adequately closed, and that no concerning clot has developed on the implant.
If the scan shows an incomplete seal or another problem, the healthcare team may recommend continued medication, additional imaging, or further treatment.
Watchman Device vs. Blood Thinners: What's the Difference?
Both approaches aim to reduce stroke risk, but they work differently.
| Feature | Watchman Device | Blood-Thinning Medicines |
|---|---|---|
| How it works | Seals the left atrial appendage to prevent clots there from entering circulation | Reduce the blood's ability to form harmful clots |
| Type of treatment | Permanent heart implant placed through a catheter | Medication taken on a prescribed schedule |
| Main consideration | Requires an invasive procedure with associated risks | Can increase bleeding risk during treatment |
| Long-term medication | Some patients may eventually stop oral anticoagulants | Often requires ongoing anticoagulant use |
| Heart rhythm control | Does not correct AFib | Anticoagulants do not correct AFib |
The choice is not simply between having an implant and taking no medicine. Watchman recipients need medication during healing, and some may require long-term anticoagulation for other medical reasons.
A cardiologist considers how well medication is tolerated, the person's risk of stroke and bleeding, and the risks associated with implantation before recommending either option.
Does the Watchman Device Cure Atrial Fibrillation?
No. The Watchman device does not stop atrial fibrillation, restore a normal heart rhythm, or prevent episodes of an irregular heartbeat.
It addresses one important complication of AFib: the possibility of blood clots forming in the left atrial appendage and causing a stroke.
AFib management may still involve heart-rate medications, rhythm-control medicines, electrical cardioversion, or catheter ablation, depending on the patient's condition.
The American Heart Association describes left atrial appendage closure as a stroke-prevention option within the broader treatment of atrial fibrillation, alongside treatments that address heart rate and rhythm.
When Should You Contact a Doctor After Implantation?
During recovery, unusual or worsening symptoms should be assessed promptly, particularly if they could indicate bleeding, infection, or a problem affecting the heart.
Examples of concerning symptoms include:
- Increasing pain, swelling, or bleeding near the catheter insertion site.
- Fever or spreading redness around the procedure site.
- New or worsening shortness of breath.
- Persistent chest discomfort or unusual palpitations.
- Marked dizziness or fainting.
Seek emergency medical care for sudden weakness on one side of the body, difficulty speaking, facial drooping, sudden vision changes, severe chest pain, or fainting with significant breathing difficulty. These can be signs of a medical emergency, including stroke or a serious heart complication.
Keeping scheduled follow-up appointments and taking prescribed medicines are essential parts of recovery.
Is the Watchman Device the Right Choice for Everyone With AFib?
The Watchman device is an important stroke-prevention option, but it is not necessary or appropriate for everyone with atrial fibrillation.
For people who can safely take anticoagulant medication, continued medication may be the preferred treatment. For others who have an increased stroke risk and cannot safely remain on long-term blood thinners, left atrial appendage closure may offer a useful alternative.
A cardiologist or heart rhythm specialist can review the patient's medical history, current medications, imaging results, and treatment preferences to determine whether the device is suitable.
The key consideration is achieving effective stroke prevention while balancing the risks of medication and an invasive procedure.